Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by <sup>1</sup>H-NMR Spectrometry

<div>The aberrant metabolic pathways using the relative concentrations of differential metabolites from NMR spectra of serum samples in the pathway analysis module of MetaboAnalyst 3.0. (a) Colorectal polyps vs. controls; (b) CRC vs. control.</div>

Disease Markers

fig3

Figure 3

Figure 3: Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by <sup>1</sup>H-NMR Spectrometry 

Disease Markers

Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by 1H-NMR Spectrometry

Figure 3

Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by ¹H-NMR Spectrometry